scholarly journals A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria

PLoS ONE ◽  
2017 ◽  
Vol 12 (11) ◽  
pp. e0187376 ◽  
Author(s):  
Mark M. Fukuda ◽  
Srivicha Krudsood ◽  
Khadeeja Mohamed ◽  
Justin A. Green ◽  
Sukhuma Warrasak ◽  
...  
2018 ◽  
Vol 67 (10) ◽  
pp. 1543-1549 ◽  
Author(s):  
Cindy S Chu ◽  
Aung Pyae Phyo ◽  
Khin Maung Lwin ◽  
Htun Htun Win ◽  
Thida San ◽  
...  

Vivax malaria relapses frequently even in low-transmission settings. Chloroquine delays but does not prevent recurrences. Adding primaquine to a slowly eliminated schizonticide significantly reduces recurrences and improves hematocrit, but this advantage is offset by hemolysis in G6PD-deficient females.


The Lancet ◽  
2014 ◽  
Vol 383 (9922) ◽  
pp. 1049-1058 ◽  
Author(s):  
Alejandro Llanos-Cuentas ◽  
Marcus V Lacerda ◽  
Ronnatrai Rueangweerayut ◽  
Srivicha Krudsood ◽  
Sandeep K Gupta ◽  
...  

PLoS ONE ◽  
2011 ◽  
Vol 6 (1) ◽  
pp. e14501 ◽  
Author(s):  
Yi Poravuth ◽  
Duong Socheat ◽  
Ronnatrai Rueangweerayut ◽  
Chirapong Uthaisin ◽  
Aung Pyae Phyo ◽  
...  

2005 ◽  
Vol 73 (6) ◽  
pp. 1108-1111 ◽  
Author(s):  
MICHAEL W. DUNNE ◽  
VAS DEV ◽  
NEENA VALECHA ◽  
NEERU SINGH ◽  
C. USHA DEVI ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document